Download Citation
Article Source:
Alzheimer's Therapeutics Targeting Amyloid Beta 1–42 Oligomers II: Sigma-2/PGRMC1 Receptors Mediate Abeta 42 Oligomer Binding and Synaptotoxicity
Izzo NJ,
Xu J,
Zeng C,
Kirk MJ,
Mozzoni K,
et al.
(2014)
Alzheimer's Therapeutics Targeting Amyloid Beta 1–42 Oligomers II: Sigma-2/PGRMC1 Receptors Mediate Abeta 42 Oligomer Binding and Synaptotoxicity.
PLOS ONE 9(11): e111899.
https://doi.org/10.1371/journal.pone.0111899